Phase II Study of Eltrombopag in Combination With Decitabine in Subjects With Advanced Myelodysplastic Syndrome
Phase of Trial: Phase II
Latest Information Update: 08 Jan 2019
Price : $35 *
At a glance
- Drugs Decitabine (Primary) ; Eltrombopag (Primary)
- Indications Acute myeloid leukaemia; Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 03 Jan 2019 Status changed from active, no longer recruiting to discontinued.
- 11 Jan 2018 Planned End Date changed from 1 Mar 2018 to 1 Mar 2019.
- 11 Jan 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.